XML 48 R36.htm IDEA: XBRL DOCUMENT v3.26.1
Net (Loss) Income per Share - Schedule of Reconciliation of the Numerator and Denominator Used in the Calculation of Basic and Diluted Net Income (Loss) per Share of Class A Common Stock (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Numerator:        
Net (loss) income $ (13,054) $ (7,380) $ 11,080 $ (13,597)
Less: Net loss attributable to noncontrolling interests 0 (1,334) 0 (2,459)
Net (loss) income attributable to common shareholders of vTv Therapeutics Inc., basic (13,054) (6,046) 11,080 (11,138)
Numerator:        
Net (loss) income (13,054) (7,380) 11,080 (13,597)
Less: Net loss attributable to noncontrolling interests 0 (1,334) 0 (2,459)
Net (loss) income attributable to common shareholders of vTv Therapeutics Inc diluted $ (13,054) $ (6,046) $ 11,080 $ (11,138)
Class A Common Stock        
Denominator:        
Weighted average vTv Therapeutics Inc. Class A common stock (in shares) 12,409,316 6,587,070 12,409,297 6,584,969
Basic net (loss) income per share of vTv Therapeutics Inc. Class A common stock (in usd per share) $ (1.05) $ (0.92) $ 0.89 $ (1.69)
Denominator:        
Weighted average vTv Therapeutics Inc. Class A common stock (in shares) 12,409,316 6,587,070 14,541,788 6,584,969
Diluted net (loss) income per share of vTv Therapeutics Inc. Class A common stock (in usd per share) $ (1.05) $ (0.92) $ 0.76 $ (1.69)